Back
Harrow 10K Form
Sell
39
HROW
Harrow
Last Price:
36.36
Seasonality Move:
0.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HROW News And Ratings
See the #1 stock for the next 7 days that we like better than HROW
HROW Financial Statistics
Sales & Book Value
| Annual Sales: | $130.19M |
|---|---|
| Cash Flow: | $2.35M |
| Price / Cash Flow: | 453.84 |
| Annual Sales: | $1.63 |
| Price / Book: | 23.18 |
Profitability
| EPS (TTM): | -0.95000 |
|---|---|
| Net Income (TTM): | $-33.41M |
| Gross Margin: | $90.55M |
| Return on Equity: | -51.9% |
| Return on Assets: | -10.76% |
Harrow Earnings Forecast
Key Harrow Financial Ratios
- The Gross Profit Margin over the past 17 years for HROW is 69.55%.
- The Selling, General & Administrative Expenses for HROW have been equal to 63.82% of Gross Profit Margin.
- The Research & Development expenses have been 5.11% of Revenue.
- The Interest Expense is -87.35% of Operating Income.
- The Net Earning history of HROW is -18.75% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 9 years.
Harrow Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | HROW |
| CUSIP: | 415858 |
| Website: | harrow.com |
Debt
| Debt-to-Equity Ratio: | 3.21 |
|---|---|
| Current Ratio: | 1.55 |
| Quick Ratio: | 1.33 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 42.64 |